Par Pharmaceutical

From WikiCover

Jump to: navigation, search

Par Pharmaceutical develops, manufactures, and markets generic drugs and innovative branded pharmaceuticals for specialty markets.


On December 28, 2007, Par Pharmaceutical Companies provided an update on the development status of its three, in-licensed, proprietary pipeline products: pafuramidine, Loramyc (miconazole Lauriad), and Zensana (ondansetron). These three products represent the current product pipeline of Strativa Pharmaceuticals, Par's proprietary products division.


Website: http://www.parpharm.com/

Name (required):

Comment: